- gsearch

- gsearch

CDC Stacks Public Health Publications

Search Results

Morbidity and Mortality Weekly Report (MMWR) Morbidity and Mortality Weekly Report (MMWR)

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:
Volume
Series
Publication Year
  • x
    2022 (495)
Medical Subject
Personal Author
Corporate Author
Place as Subject
Resource Type General
Resource Type Specific
Keywords
x 2022
  • Mental Health Surveillance Among Children  US 20132019
    Mental Health Surveillance Among Children — U.S. 2013–2019
    :
    No Description
  • Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratoryconfirmed SARSCoV2 Infection During Periods of B16172 Delta and B11529 Omicron Variants Predominance  One Hospital California July 15September 23 2021 and December 21 2021January 27 2022
    Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variants Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022
    :
    :
  • Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARSCoV2 Infection  California FebruaryDecember 2021
    Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
    :
    :
  • SARSCoV2 Infection and Hospitalization Among Adults Aged 18 Years by Vaccination Status Before and During SARSCoV2 B11529 Omicron Variants Predominance  Los Angeles County California November 7 2021January 8 2022
    SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variants Predominance — Los Angeles County, California, November 7, 2021–January 8, 2022
    :
    :
  • People Who Reported Always Wearing a Mask in Indoor Public Settings Were Less Likely to Test Positive for COVID19 Than People Who Didnt
    People Who Reported Always Wearing a Mask in Indoor Public Settings Were Less Likely to Test Positive for COVID-19 Than People Who Didn't
    :
    :
  • Cardiac Complications After SARSCoV2 Infection and MRNA COVID19 Vaccination  PCORnet United States January 2021January 2022
    Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022
    :
    :
  • Use of Athome COVID19 Tests  US August 23 2021March 12 2022
    Use of At-home COVID-19 Tests — U.S. August 23, 2021–March 12, 2022
    :
    :
  • Ventilation Improvement Strategies Among K12 Public Schools  the National School COVID19 Prevention Study United States February 14March 27 2022
    Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022
    :
    :
  • Dispensing of Oral Antiviral Drugs for Treatment of COVID19 by Zip Codelevel Social Vulnerability  United States December 23 2021May 21 2022
    Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022
    :
    :
  • Hospitalization and Emergency Department Encounters for COVID19 After Paxlovid Treatment  California December 2021May 2022
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022
    :
    :
  • Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and PfizerBioNTech COVID19 Vaccines in Children Aged 6 Months5 Years  United States June 2022
    Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
    :
    :
  • Interim Analysis of Acute Hepatitis of Unknown Etiology in Children Aged 10 Years  United States October 2021June 2022
    Interim Analysis of Acute Hepatitis of Unknown Etiology in Children Aged <10 Years — United States, October 2021–June 2022
    :
    :
  • Rapid Diagnostic Testing for Response to the Monkeypox Outbreak  Laboratory Response Network US May 17June 30 2022
    Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, U.S. May 17–June 30, 2022
    :
    :
  • Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID19 Pandemic  US January 2019January 2022
    Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — U.S. January 2019–January 2022
    :
    :
  • Pediatric Emergency Department Visits Before and During the COVID19 Pandemic  US January 2019January 2022
    Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — U.S. January 2019–January 2022
    :
    :
  • During the Pandemic Girls Ages 1217 Had More Emergency Department Visits for Some Mental Health Conditions
    During the Pandemic, Girls Ages 12-17 Had More Emergency Department Visits for Some Mental Health Conditions
    :
    :
  • In Households of People with COVID19 Caused by the Omicron Variants Spread Was Common
    In Households of People with COVID-19 Caused by the Omicron Variants, Spread Was Common
    :
    :
  • Hospitalization of Infants and Children Aged 04 Years with Laboratoryconfirmed COVID19  COVIDNET 14 States March 2020February 2022
    Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
    :
    :
  • Effectiveness of 2dose BNT162b2 Pfizer BioNTech MRNA Vaccine in Preventing SARSCoV2 Infection Among Children Aged 511 Years and Adolescents Aged 1215 Years  PROTECT Cohort July 2021February 2022
    Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
    :
    :
  • COVID19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta
    COVID-19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta.
    :
    :
1 - 20 / 495
Sort By: